Eli Lilly and Company News Headlines

LLY 
$66.53
*  
0.06
0.09%
Get LLY Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Week In Review: GSK Ends China Bribery Investigation By Paying $489 Million Fine
9/21/2014 7:11:00 AM - Seeking Alpha

Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog
9/19/2014 4:50:00 PM - Zacks.com

Dow Chemical (DOW) Gets Key USDA Nod for Enlist Traits - Analyst Blog
9/19/2014 1:40:00 PM - Zacks.com

U.S. Hot Stocks: Hot Stocks to Watch
9/19/2014 9:28:00 AM - Dow Jones Business News

It Takes Less Than 15 Minutes To Buy VVUS Shares!
9/19/2014 8:51:00 AM - Seeking Alpha

It's Time To Cross The T's...
9/19/2014 7:02:00 AM - RTT News

Lilly Says FDA Approves Type 2 Diabetes Drug Trulicity
9/18/2014 11:42:00 PM - RTT News

Lilly's Type 2 Diabetes Drug Trulicity Gets FDA OK -- 2nd Update
9/18/2014 7:28:00 PM - Dow Jones Business News

Lilly's Type 2 Diabetes Drug Trulicity Gets FDA OK -- Update
9/18/2014 5:45:00 PM - Dow Jones Business News

Lilly's Type 2 Diabetes Drug Trulicity Gets FDA Approval
9/18/2014 4:27:00 PM - Dow Jones Business News

Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog
9/18/2014 4:16:00 PM - Zacks.com

Lilly's Phase III Trial Of Cyramza With Paclitaxel Meets Endpoints
9/18/2014 8:35:00 AM - RTT News

UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
9/17/2014 6:40:00 PM - Zacks.com

Sanofi: Stiff Competition Will Impact Future Performance
9/17/2014 12:01:00 PM - Seeking Alpha

Notable ETF Inflow Detected - VHT, UNH, MDT, LLY
9/17/2014 11:15:43 AM - BNK Invest

AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog
9/16/2014 5:20:00 PM - Zacks.com

How Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval?
9/16/2014 12:36:00 PM - TheStreet

Update: AstraZeneca Announces Licensing Agreement
9/16/2014 11:25:00 AM - Seeking Alpha

Eli Lilly Will Soon Emerge As A Star
9/16/2014 9:49:00 AM - Seeking Alpha

U.S. Hot Stocks: Hot Stocks to Watch
9/16/2014 9:29:00 AM - Dow Jones Business News

AstraZeneca, Lilly To Jointly Develop AZD3293 For Alzheimer's Disease - Update
9/16/2014 2:57:00 AM - RTT News

European Markets Indicate Mixed Open
9/16/2014 2:41:00 AM - RTT News

AstraZeneca, Eli Lilly Form Alzheimer's Disease Treatment Alliance
9/16/2014 2:35:00 AM - Dow Jones Business News

AstraZeneca, Lilly Reach Deal On BACE Inhibitor AZD3293 For Alzheimer's Disease
9/16/2014 2:13:00 AM - RTT News

Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
9/15/2014 4:30:00 PM - Zacks.com